Inhibition of Serotonin-Induced Vascular Smooth Muscle Cell Proliferation by Sarpogrelate

• Published in: The Journal of pharmacology and experimental therapeutics 1999-09, Vol.290 (3), p.1475-1481
• Main Authors: Sharma, S K, Zahradka, P, Chapman, D, Kumamoto, H, Takeda, N, Dhalla, N S
• Format: Article
• Language: English
• Subjects: Animals; Cell Division - drug effects; Cells, Cultured; DNA - metabolism; Flow Cytometry; Growth Inhibitors - pharmacology; Male; Muscle, Smooth, Vascular - cytology; Muscle, Smooth, Vascular - drug effects; Muscle, Smooth, Vascular - metabolism; Rats; Rats, Sprague-Dawley; Serotonin - pharmacology; Serotonin - physiology; Serotonin Antagonists - pharmacology; Succinates - pharmacology; Thymidine; Tritium
• ISSN: 0022-3565; 1521-0103

Antiproliferative behavior of sarpogrelate (Anplag, MCI-9042, (±)-1-[2-[2-(3-methoxyphenyl)ethyl]phenoxy]-3-(dimethylamino)-2-propyl hydrogen succinate hydrochloride), a serotonin 2A (5-HT2A) receptor antagonist, was established using radioactive incorporation of [ 3 H]thymidine, [ 3 H]uridine, and [ 3 H]phenylalanine in cultured rat aortic smooth muscle cells in response to a 5-HT-induced cytokine trigger. Fluorescence-activated cell sorting was used to confirm these observations. 5-HT-induced DNA, RNA, and protein synthesis were inhibited maximally at a concentration of 1 μM sarpogrelate. Although other cytokines such as platelet-derived growth factor and endothelin also induced DNA, RNA, and protein synthesis in rat aortic smooth muscle cells, cell proliferation was not influenced by sarpogrelate, even at large pharmacological concentrations (10 μM). Sarpogrelate’s antiproliferative actions were found to be more potent than ketanserin. These data indicate that sarpogrelate operates as a specific inhibitor of 5-HT-mediated cell proliferation and is a good candidate for preventing serotonin-induced neointimal hyperplasia.